Breast cancer risk assessment among low-income women of color in primary care: A pilot study

Journal of Oncology Practice

Volumn 11, Issue 4, 2015, Pages e460-e467

  Anderson, Emily E ^a   Tejeda, Silvia ^a   Childers, Kimberly ^a   Stolley, Melinda R ^a   Warnecke, Richard B ^a   Hoskins, Kent F ^a  

^a LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; COLOR; DEMOGRAPHY; EVALUATION STUDY; FEASIBILITY STUDY; FEMALE; HEALTH CARE SURVEY; HEALTH CENTER; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; MEDICAID; MEDICAL ASSESSMENT; MEDICARE; PATIENT WORRY; PILOT STUDY; PRIMARY MEDICAL CARE; RISK ASSESSMENT; TASK PERFORMANCE; ADOLESCENT; AFRICAN AMERICAN; BREAST NEOPLASMS; DIAGNOSTIC IMAGING; ETHNOLOGY; GENETIC SCREENING; GENETICS; HEALTH STATUS; HISPANIC; MIDDLE AGED; PATIENT ATTITUDE; PATIENT REFERRAL; POVERTY; PRIMARY HEALTH CARE; RISK FACTOR; STATISTICS AND NUMERICAL DATA; UNITED STATES; YOUNG ADULT;

ADOLESCENT; ADULT; AFRICAN AMERICANS; AGED; BREAST NEOPLASMS; FEMALE; GENETIC TESTING; HEALTH STATUS; HISPANIC AMERICANS; HUMANS; MAMMOGRAPHY; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; PILOT PROJECTS; POVERTY; PRIMARY HEALTH CARE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84937706229     PISSN: 15547477     EISSN: 1935469X     Source Type: Journal    
DOI: 10.1200/JOP.2014.003558     Document Type: Article

References (40)

1. Moyer VA: Medications for risk reduction of primary breast cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 159:698-708, 2013
2. Moyer VA: Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 160:271-281, 2014
3. Robson ME, Storm CD, Weitzel J, et al: American Society of Clinical Oncology policy statement update: Genetic and genomic testing for cancer susceptibility. J Clin Oncol 28:893-901, 2010
4. Saslow D, Boetes C, Burke W, et al: American Cancer Society guidelines for breast screening with MRI as an adjunct to mammography. CA Cancer J Clin 57:75-89, 2007
5. Visvanathan K, Hurley P, Bantug E, et al: Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31:2942-2962, 2013
6. Burke W, Culver J, Pinsky L, et al: Genetic assessment of breast cancer risk in primary care practice. Am J Med Genet A 149A:349-356, 2009
7. Guerra CE, Sherman M, Armstrong K: Diffusion of breast cancer risk assessment in primary care. J Am Board Fam Med 22:272-279, 2009
8. Katapodi MC, Lee KA, Facione NC, et al: Predictors of perceived breast cancer risk and the relation between perceived risk and breast cancer screening: A meta-analytic review. Prev Med 38:388-402, 2004
9. Katapodi MC, Dodd MJ, Lee KA, et al: Underestimation of breast cancer risk: Influence on screening behavior. Oncol Nurs Forum 36:306-314, 2009
10. Glenn B, Chawla N, Bastani R: Barriers to genetic testing for breast cancer risk among ethnic minority women: An exploratory study. Ethn Dis 22:267-273, 2012
11. Hughes C, Gomez-Caminero A, Benkendorf J, et al: Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk. Patient Educ Couns 32:51-62, 1997
12. Thompson HS, Valdimarsdottir HB, Jandorf L, et al: Perceived disadvantages and concerns about abuses of genetic testing for cancer risk: Differences across African American, Latina and Caucasian women. Patient Educ Couns 51:217-227, 2003
13. Owens WL, Gallagher TJ, Kincheloe MJ, et al: Implementation in a large health system of a program to identify women at high risk for breast cancer. J Oncol Pract 7:85-88, 2011
14. Mays D, Sharff M, DeMarco T, et al: Outcomes of a systems-level intervention offering breast cancer risk assessments to low-income underserved women. Fam Cancer 11:493-502, 2012
15. Mandelblatt JS, Schechter CB, Yabroff KR, et al: Benefits and costs of interventions to improve breast cancer outcomes in African American women. J Clin Oncol 22:2554-2566, 2004
16. US Department of Health and Human Services: Healthy People 2010: Understanding and Improving Health (ed 2). Washington, DC, US Government Printing Office, 2000
17. Armstrong K, Eisen A, Weber B: Assessing the risk of breast cancer. N Engl J Med 342:564-571, 2000
18. Daly MB, Axilbund JE, Buys S, et al: Genetic/familial high-risk assessment: Breast and ovarian. J Natl Compr Canc Netw 8:562-594, 2010
19. Freedman AN, Yu B, Gail MH, et al: Benefit/risk assessment for breast cancer chemoprevention with raloxifene or tamoxifen for women age 50 years or older. J Clin Oncol 29:2327-2333, 2011
20. Nelson HD, Tyne K, Naik A, et al: Screening for breast cancer: An update for the U.S. Preventive Services Task Force. Ann Intern Med 151:727-737, 2009
21. Gail MH, Brinton LA, Byar DP, et al: Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst 81:1879-1886, 1989
22. Gail MH, Costantino JP, Pee D, et al: Projecting individualized absolute invasive breast cancer risk in African American women. J Natl Cancer Inst 99:1782-1792, 2007
23. Claus EB, Risch N, Thompson WD: Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction. Cancer 73:643-651, 1994
24. Visvanathan K, Hurley P, Bantug E, et al: Use of pharmacologic interventions for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline. J Clin Oncol 31:2942-2962, 2013
25. Hoskins KF, Zwaagstra A, Ranz M: Validation of a tool for identifying women at high risk for hereditary breast cancer in population-based screening. Cancer 107:1769-1776, 2006
26. Teller P, Hoskins KF, Zwaagstra A, et al: Validation of the pedigree assessment tool (PAT) in families with BRCA1 and BRCA2 mutations. Ann Surg Oncol 17:240-246, 2010
27. National Comprehensive Cancer Network: NCCN guidelines: Breast cancer screening and diagnosis, 2013. www.nccn.org/professionals/physician-gls/f-guidelines-nojava.asp
28. Waters E, McNeel T, Stevens W, et al: Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Res Treat 134:875-880, 2012
29. National Comprehensive Cancer Network: NCCN guidelines: Breast cancer risk reduction, 2013. www.nccn.org/professionals/physician-gls/f-guidelines-nojava.asp
30. Buchanan AH, Skinner CS, Rawl SM, et al: Patients' interest in discussing cancer risk and risk management with primary care physicians. Patient Educ Couns 57:77-87, 2005
31. Centers for Disease Control and Prevention: Behavioral risk factor surveillance system survey questionnaire. www.cdc.gov/brfss/questionnaires/index.htm
32. Champion VL, Monahan PO, Springston JK, et al: Measuring mammography and breast cancer beliefs in African American women. J Health Psychol 13:827-837, 2008
33. Lerman C, Trock B, Rimer BK, et al: Psychological side effects of breast cancer screening. Health Psychol 10:259-267, 1991
34. Shea J, Micco E, Dean L, et al: Development of a revised health care system distrust scale. J Gen Intern Med 23:727-732, 2008
35. Underhill ML, Kiviniemi MT: The association of perceived provider-patient communication and relationship quality with colorectal cancer screening. Health Educ Behav 39:555-563, 2012
36. Harris P, Taylor R, Thielke R, et al: Research electronic data capture (REDCap): A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 42:377-381, 2009
37. Bartle-Haring S, Toviessi P, Katafiasz H: Predicting the use of individualized risk assessment for breast cancer. Womens Health Issues 18:100-109, 2008
38. Andersen MR, Smith R, Meischke H, et al: Breast cancer worry and mammography use by women with and without a family history in a population-based sample. Cancer Epidemiol Biomarkers Prev 12:314-320, 2003
39. Anderson E, Hoskins K: Individual breast cancer risk assessment in underserved populations: Integrating empirical bioethics and health disparities research. J Health Care Poor Underserved 23:34-46, 2012 (suppl)
40. Schwartz MD, Rimer BK, Daly M, et al: A randomized trial of breast cancer risk counseling: The impact on self-reported mammography use. Am J Public Health 89:924-926, 1999